ZYNLONTA
ZYNLONTA
Approved
DIN Number
02556138
Drug Class
Human
Market Date
N/A
Company
HC
Swedish Orphan Biovitrum AB (Publ)
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02556138
AIG Number0166604001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L01FX22 LONCASTUXIMAB TESIRINE
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
LONCASTUXIMAB TESIRINEActive
Strength: 10 MG / VIAL
Monograph: LONCASTUXIMAB TESIRINE